25 February 2020

In oculopharyngeal muscular dystrophy (OPMD), muscle strength slowly decreases due to a breakdown of muscle cells. Whereas OPMD may affect many muscles, the eyes (oculo) and the throat (pharynx) are disproportionately affected. OPMD is a hereditary muscle disease whose disease mechanism is not yet completely clear. The Biobank OPMD contains clinical data and residual biomaterial from a study where the efficacy of the protein degradation system was investigated in different cell models for OPMD. The study further examined whether recovery from degradation with the aid of medication resulted in less muscle weakness.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


Radboud Biobank Office Relocation

30 January 2025

We would like to inform you about the upcoming relocation of the Radboud Biobank office.

read more

Request for DNA samples from stored whole blood and/or saliva

30 January 2025

There are biobank collections that collected whole blood and saliva before joining the Radboud Biobank to isolate DNA from them later.

read more

Great news!

30 January 2025

We have good news for both new and existing collections and projects interested in isolating PBMCs (Peripheral Blood Mononuclear Cells)!

read more

BBMRI-ERIC launches 10-Year Roadmap: Biobanking for a Healthier World

30 January 2025

BBMRI-ERIC, the European research infrastructure for biobanking and biomolecular resources, has launched its visionary 10-Year Roadmap (2025-2035).

read more

New business model for the Radboud Biobank

24 November 2024

The Radboudumc Board of Directors decided, after receiving advice from the UMC council, to change the Radboud Biobank business model.  

read more